Mr. Speaker, in circumstances where the shortage of important drugs does occur, Health Canada will work with the provinces, territories, manufacturers and health professionals to minimize the impact.
Canadians can also be assured that Health Canada is ready to respond on a priority basis. For example, we can help authorize access to alternatives on an emergency basis and expedite the review of manufacturers' changes or new suppliers. We will use the right tools for the situation at hand. The time required for each will depend on the specific request.
We expect Sandoz, as an example, to post all of its drug shortage information on its website and existing public websites at the University of Saskatchewan Drug Information Services. An equivalent French website has been established. Health Canada is closely monitoring the timeliness and completeness of the information that Sandoz has provided to determine if changes are needed to make sure that Canadians have access to the information they need. We are encouraged by its response.